Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Measles: high risk of delayed fatal consequences

22.07.2013
After a measles infection, infants in particular are at high risk of developing a fatal encephalitis, even years later. A new study has now revealed that this risk is significantly higher than assumed.

“Measles used to be one of the deadliest and most feared diseases in the world. Then along came the vaccination, and the horror of this supposed childhood illness was forgotten. Now the viruses are spreading again, in Germany as well – as a delayed consequence of vaccination fatigue and misinformation.”

This was the headline of a recent article in the news magazine Der Spiegel about the “delayed consequences of vaccine fear”. The article drew on the news of measles outbreaks in Bavaria, Berlin, and North Rhine-Westphalia.

Now, scientists from the University of Würzburg and the Bavarian Health and Food Safety Authority (LGL) in Oberschleißheim have revealed that a measles infection, especially in infants, is associated with a high risk of fatal complications. Whereas it was previously assumed that a specific delayed complication of measles occurs in one in every 100,000 cases, they calculated the average risk for children below 5 years of age to be 1 in 3,300. The researchers have published their study in the scientific journal PLOS One.

SSPE: the dreaded delayed complication

Subacute Sclerosing Panencephalitis (SSPE): this is the medical name for the dreaded delayed complication of a measles infection – an inflammation of the brain. “SSPE mainly affects children and does not tend to develop until several years after an acute measles infection. It leads to a gradual loss of all mental faculties and culminates in a vegetative state, in which the sufferer dies after a few months or even years. There is no treatment for SSPE,” is how Benedikt Weißbrich describes the symptoms of this disease. Weißbrich is a Research Associate at the University of Würzburg’s Institute of Virology and Immunobiology and one of the coordinators of the study.

In older literature, the risk of occurrence of SSPE after acute measles was cited as 1 in 100,000. “However, more recent studies from Great Britain and the USA suggest that the risk is far greater,” says Weißbrich. It is possible that the risk may have increased over time. Though, it is just as conceivable that the case numbers were not previously recorded properly, particularly for very young children. It is in fact difficult to calculate the SSPE risk because the time between an acute measles infection and the development of SSPE may span many years.

31 SSPE cases in six years

There was no relevant data for Germany. For this reason, the Institute of Virology and Immunobiology at the University of Würzburg and the Bavarian Health and Food Safety Authority conducted a joint study and examined the SSPE risk.

“We recorded SSPE cases in children who had been treated in German hospitals between 2003 and 2009,” explains Weißbrich. The SSPE cases diagnosed at the University of Würzburg and the German Pediatric Surveillance Unit (ESPED) were used as the data source. A total of 31 children with a diagnosis of SSPE were identified by the researchers. To enable them then to calculate the SSPE risk, they next had to find out when and where these children had been infected with measles. “This information was admittedly patchy, but for 13 children it was fair to assume that they had become infected with measles in Germany between 1994 and 2001,” says Weißbrich. All the children were below the age of five at the time of their measles infection.

The scientists were able to extrapolate the total number of measles cases during this period from hospital statistics for the relevant age group. The figure was 42,600. This produced an SSPE risk of 1 in 3,300 after measles virus infections in the first five years of life.

Fatal consequences for the first year of life

“Our study provides data for the very first time on the incidence of SSPE cases in Germany and reveals that the risk of SSPE with measles infections in the first few years of life is considerable and certainly not negligible,” concludes Weißbrich. What is more, the study shows that the calculated average risk of 1 in 3,300 for the under-five age group is probably much higher for children in the first year of life and correspondingly lower for children in the fifth year of life.

The implications of this are significant: a measles vaccination protects against SSPE, but it is not administered until after a child is eleven months old. “This means that the very children for whom the SSPE risk is highest, children in their first year of life, cannot be protected against SSPE by a measles vaccination,” warns Weißbrich and therefore urgently appeals to all parents to have their children vaccinated. “Only if as many people as possible are immune to measles will it be possible to eliminate this disease and thereby protect children in the first year of life from a terrible disease,” says the researcher. However, current reported data with more than 1,000 cases of measles already in 2013 reveal that Germany still has a long way to go.

About measles

Measles is a viral infection from which more than 100,000 children worldwide still die annually. In Germany, too, there continue to be deaths from measles. These are partly due to complications caused by the measles infection, which occur during an acute attack, such as encephalitis and pneumonia. Another reason is that the measles virus causes the encephalitis SSPE, described above, as a delayed complication that is almost always fatal.

Schönberger K, Ludwig M-S, Wildner M, Weissbrich B (2013) Epidemiology of Subacute Sclerosing Panencephalitis (SSPE) in Germany from 2003 to 2009: A Risk Estimation. PLoS ONE 8(7): e68909. doi:10.1371/journal.pone.0068909

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068909

Contact

Dr. Benedikt Weißbrich, T: +49 (0)931 201-49962;
e-mail: weissbrich@vim.uni-wuerzburg.de

Gunnar Bartsch | idw
Further information:
http://www.uni-wuerzburg.de

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>